Vaishali Pharma Ltd is a leading pharmaceutical company in India, engaged in the manufacturing, marketing, and exporting of a wide range of pharmaceutical products. The company offers a variety of products including medicines, surgical items, and wellness solutions. Vaishali Pharma is known for its strong distribution network and focuses on both domestic and international markets, with exports to several countries. Vaishali Pharma Share Price on NSE as of 11 October 2024 is 211.80 INR. Here are more details on Vaishali Pharma Share Price Target 2024, 2025, 2026 to 2030.
Vaishali Pharma Ltd: Market Overview
- Open Price: ₹205.95
- High Price: ₹214.89
- Low Price: ₹203.00
- Previous Close: ₹201.71
- Volume: 624,939
- Value (Lacs): ₹1,330.18
- VWAP: 210.52
- UC Limit: ₹242.05
- LC Limit: ₹161.36
- P/E ratio: 515.25
- Div yield: N/A
- 52-wk high: ₹214.89
- 52-wk low: ₹124.90
- Mkt cap: ₹258.27Cr
- Face Value: ₹10
Vaishali Pharma Share Price Chart
Vaishali Pharma Share Price Target Tomorrow 2024 To 2030
| Vaishali Pharma Share Price Target Years | Share Price Target |
| 2024 | ₹252 |
| 2025 | ₹299 |
| 2026 | ₹345 |
| 2027 | ₹387 |
| 2028 | ₹433 |
| 2029 | ₹505 |
| 2030 | ₹580 |
Vaishali Pharma Share Price Target 2024
Vaishali Pharma share price target 2024 Expected target could be ₹252. Here are three key factors that could affect Vaishali Pharma’s share price target in 2030:
- Expansion into International Markets: Vaishali Pharma’s increasing focus on exports and expanding its presence in global markets can drive revenue growth. Successful penetration into new regions may positively impact its share price.
- Product Portfolio Diversification: The company’s continuous efforts to diversify its product range, including pharmaceutical and wellness products, can strengthen its market position. Offering more solutions in high-demand categories could boost investor confidence.
-
Regulatory Approvals and Compliance: Obtaining timely approvals from regulatory bodies for its products, both in domestic and international markets, will be critical. Adherence to high-quality standards will ensure smooth business operations and support share price growth.
Vaishali Pharma Share Price Target 2025
Vaishali Pharma share price target 2025 Expected target could be ₹299. Here are three key factors that could affect Vaishali Pharma’s share price target in 2025.
- Innovation and R&D Investments: Vaishali Pharma’s commitment to research and development can significantly enhance its competitive edge. Innovations in drug formulation and new product introductions can attract more customers and boost revenue, positively impacting the share price.
- Strategic Partnerships and Collaborations: Forming alliances with other pharmaceutical companies and research institutions can facilitate access to new technologies and markets. Such partnerships can enhance product offerings and improve distribution channels, driving growth and investor interest.
-
Market Demand and Trends: The increasing demand for generic drugs and healthcare products, fueled by an aging population and rising health awareness, presents significant growth opportunities. Vaishali Pharma’s ability to align its products with market trends will be crucial for sustaining growth and enhancing its share price.
Vaishali Pharma Share Price Target 2030
Vaishali Pharma share price target 2030 Expected target could be ₹580. Here are three key factors that could affect Vaishali Pharma’s share price target in 2030.
- Regulatory Approvals and Compliance: The pharmaceutical industry is heavily regulated, and obtaining necessary approvals for new drugs can significantly influence Vaishali Pharma’s growth. Streamlined processes for regulatory compliance and faster approval times will enhance the company’s ability to introduce new products, driving revenue and share price growth.
- Expansion into Emerging Markets: Targeting emerging markets presents a substantial growth opportunity for Vaishali Pharma. By establishing a presence in countries with growing healthcare needs and increasing purchasing power, the company can diversify its revenue streams and reduce dependency on established markets.
-
Sustainability and Ethical Practices: As the industry shifts towards sustainable and ethical practices, Vaishali Pharma’s commitment to environmentally friendly manufacturing and responsible sourcing can enhance its brand reputation. This focus not only meets consumer demand but can also attract socially responsible investors, positively impacting the share price in the long term.
Shareholding Pattern For Vaishali Pharma Ltd
- Promoters:Â 31.6%
- FII:Â 0%
- DII:Â 0%
- Public:Â 68.4%
FOR MORE DETAIL FOLLOW THE OFFICIAL WEBSITE: http://www.vaishalipharma.com/
Vaishali Pharma Ltd Financials
| (INR) | 2024 | Y/Y change |
| Revenue | 862.80M | 23.85% |
| Operating expense | 112.35M | 84.51% |
| Net income | 7.19M | -89.11% |
| Net profit margin | 0.83 | -91.24% |
| Earnings per share | — | — |
| EBITDA | 11.38M | -87.55% |
| Effective tax rate | 22.37% | — |
Read Also:- Freshworks Share Price Target Tomorrow 2024 To 2030- Recent Graph, Market Overview
